A citation-based method for searching scientific literature

Jason Cohn, William Blazey, David Tegay, Brian Harper, Sharon Koehler, Brookshield Laurent, Vivian Chan, Min-Kyung Jung, Bhuma Krishnamachari. Breast J 2014
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
41
100

Cancer statistics, 2013.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2013
100


Attitudes and practices among internists concerning genetic testing.
Robert Klitzman, Wendy Chung, Karen Marder, Anita Shanmugham, Lisa J Chin, Meredith Stark, Cheng-Shiun Leu, Paul S Appelbaum. J Genet Couns 2013
105
100

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
R I Olivier, M van Beurden, M A C Lubsen, M A Rookus, T M Mooij, M J van de Vijver, L J van't Veer. Br J Cancer 2004
92
100

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
295
100

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Joni L Rutter, Sholom Wacholder, Angela Chetrit, Flora Lubin, Joseph Menczer, Sarah Ebbers, Margaret A Tucker, Jeffery P Struewing, Patricia Hartge. J Natl Cancer Inst 2003
69
100

Primary care providers' experiences with and perceptions of personalized genomic medicine.
June C Carroll, Tutsirai Makuwaza, Donna P Manca, Nicolette Sopcak, Joanne A Permaul, Mary Ann O'Brien, Ruth Heisey, Elizabeth A Eisenhauer, Julie Easley, Monika K Krzyzanowska,[...]. Can Fam Physician 2016
48
100

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
100

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.
Yu Chuan Tai, Susan Domchek, Giovanni Parmigiani, Sining Chen. J Natl Cancer Inst 2007
181
100

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
912
100

Physician preferences for accredited online continuing medical education.
Kevin J Young, Julie J Kim, George Yeung, Christina Sit, Sheldon W Tobe. J Contin Educ Health Prof 2011
35
100

MRI surveillance for hereditary breast-cancer risk.
Ellen Warner, Petrina A Causer. Lancet 2005
30
100

Use of cancer susceptibility testing among primary care physicians.
R Sifri, R Myers, T Hyslop, B Turner, J Cocroft, T Rothermel, J Grana, N Schlackman. Clin Genet 2003
40
100

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
100

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
695
100

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
40
100



Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
100

Male breast cancer.
Ian S Fentiman, Alain Fourquet, Gabriel N Hortobagyi. Lancet 2006
357
100

Impact of academic affiliation and training on knowledge of hereditary colorectal cancer.
V Chan, W Blazey, D Tegay, B Harper, S Koehler, B Laurent, S Lipka, J Cohn, M-K Jung, B Krishnamachari. Public Health Genomics 2014
5
100


Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
100

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
100

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
100

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
L Wideroff, S T Vadaparampil, M H Greene, S Taplin, L Olson, A N Freedman. J Med Genet 2005
109
100

A systematic review of interventions to provide genetics education for primary care.
Milena Paneque, Daniela Turchetti, Leigh Jackson, Peter Lunt, Elisa Houwink, Heather Skirton. BMC Fam Pract 2016
36
100

Prostate cancer progression and survival in BRCA2 mutation carriers.
Laufey Tryggvadóttir, Linda Vidarsdóttir, Tryggvi Thorgeirsson, Jon Gunnlaugur Jonasson, Elinborg Jona Olafsdóttir, Gudridur Helga Olafsdóttir, Thorunn Rafnar, Steinunn Thorlacius, Eirikur Jonsson, Jorunn Erla Eyfjord,[...]. J Natl Cancer Inst 2007
147
100

Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers.
Meira Epplein, Ksenia P Koon, Scott D Ramsey, John D Potter. J Clin Oncol 2005
28
100

Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.
S U Dhar, H P Cooper, T Wang, B Parks, S A Staggs, S Hilsenbeck, S E Plon. Breast Cancer Res Treat 2011
21
100

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
A R Brooks-Wilson, P Kaurah, G Suriano, S Leach, J Senz, N Grehan, Y S N Butterfield, J Jeyes, J Schinas, J Bacani,[...]. J Med Genet 2004
257
100



Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
259
100

Genetic/familial high-risk assessment: breast and ovarian.
Mary B Daly, Jennifer E Axilbund, Saundra Buys, Beth Crawford, Carolyn D Farrell, Susan Friedman, Judy E Garber, Salil Goorha, Stephen B Gruber, Heather Hampel,[...]. J Natl Compr Canc Netw 2010
160
100

Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
Deborah Cragun, Courtney Scherr, Lucia Camperlengo, Susan T Vadaparampil, Tuya Pal. Genet Test Mol Biomarkers 2016
11
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.